Perforin-2 enhances antigen-specific CTL immune response by promoting cross presentation
- Cell Death Dis. 2026 Apr 9;17(1):485. doi: 10.1038/s41419-026-08705-1.
- 1. Yunnan Provincial Key Laboratory of Public Health and Bio-safety & Department of Pathogen Biology and Immunology, Faculty of Basic Medical Science, Kunming Medical University, Kunming, China.
- 2. The Center of Experimental Teaching, Faculty of Basic Medical Science, Kunming Medical University, Kunming, China.
- 3. Department of Tuberculosis, Yunnan Clinical Medical Center for Infectious Diseases, the Third People's Hospital of Kunming (The Sixth Affiliated Hospital of Dali University), Kunming, China.
- 4. Yunnan Provincial Key Laboratory of Public Health and Bio-safety & Department of Pathogen Biology and Immunology, Faculty of Basic Medical Science, Kunming Medical University, Kunming, China. [email protected].
- 5. Key Laboratory of Sepsis and Brain Regulation in Universities of Yunnan Province, Faculty of Basic Medical Science, Kunming Medical University, Kunming, China. [email protected].
- # Contributed equally.
Antigen cross-presentation is essential for initiating CD8+ cytotoxic T lymphocyte (CTL) response. Perforin-2 (P2), a pore-forming protein constitutively expressed in dendritic cells (DCs), has been implicated in endocytic cargo escape, but its role in cross-presentation remains poorly defined. Here, we show that loss of P2 markedly impairs DC-mediated cross-presentation of both soluble and particulate antigens, leading to weakened antigen-specific CD8+ T cell responses. Additionally, P2-/- mice exhibited defective endogenous CTL responses and diminished anti-tumor immunity in melanoma models. Mechanistically, oligomerization of plasma membrane P2 promotes antigen uptake via membrane-repair-mediated macropinocytosis. In parallel, P2 limits excessive endosomal acidification, preserving antigens for efficient loading onto MHC class I molecules. These findings identify P2 as a key regulator that coordinates antigen uptake and processing to support effective cross-presentation and CD8+ T cell immunity.
-
Cat. No.Product NameDescriptionTargetResearch Area
-